NeueHealth, Inc. (NYSE:NEUE) Short Interest Up 33.7% in March

by · The Cerbat Gem

NeueHealth, Inc. (NYSE:NEUE – Get Free Report) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 12,300 shares, a growth of 33.7% from the February 28th total of 9,200 shares. Approximately 0.5% of the shares of the stock are short sold. Based on an average trading volume of 47,300 shares, the short-interest ratio is presently 0.3 days.

Insider Activity

In other NeueHealth news, CFO Jay Matushak sold 4,448 shares of the company’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $6.74, for a total transaction of $29,979.52. Following the transaction, the chief financial officer now directly owns 41,592 shares in the company, valued at approximately $280,330.08. This represents a 9.66 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO George Lawrence Mikan III sold 31,798 shares of NeueHealth stock in a transaction on Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $233,079.34. Following the sale, the chief executive officer now directly owns 146,539 shares of the company’s stock, valued at $1,074,130.87. This represents a 17.83 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 110,033 shares of company stock worth $774,560. Insiders own 64.30% of the company’s stock.

Institutional Trading of NeueHealth

A hedge fund recently bought a new stake in NeueHealth stock. Virtu Financial LLC bought a new position in shares of NeueHealth, Inc. (NYSE:NEUE – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 10,232 shares of the company’s stock, valued at approximately $76,000. Virtu Financial LLC owned approximately 0.12% of NeueHealth at the end of the most recent quarter. 63.88% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada reduced their price objective on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research note on Monday, December 9th.

Check Out Our Latest Research Report on NEUE

NeueHealth Price Performance

Shares of NYSE NEUE traded up $0.08 during midday trading on Wednesday, reaching $6.68. 4,063 shares of the stock were exchanged, compared to its average volume of 19,924. NeueHealth has a 12 month low of $3.79 and a 12 month high of $7.66. The company has a market capitalization of $55.34 million, a price-to-earnings ratio of -0.13 and a beta of 0.56. The business has a 50-day simple moving average of $6.92 and a two-hundred day simple moving average of $6.09.

NeueHealth (NYSE:NEUE – Get Free Report) last posted its earnings results on Thursday, March 20th. The company reported ($7.41) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.29) by ($5.12). The business had revenue of $232.64 million during the quarter, compared to analyst estimates of $261.80 million. NeueHealth had a negative net margin of 36.28% and a negative return on equity of 6.40%. Equities research analysts expect that NeueHealth will post -9.13 earnings per share for the current fiscal year.

About NeueHealth

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Recommended Stories